ISSN: 0733-2459

Journal Home

Journal Guideline

Journal of Clinical Apheresis Q3 Unclaimed

Wiley-Liss Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Clinical Apheresis is a journal indexed in SJR in Medicine (miscellaneous) and Hematology with an H index of 51. It has a price of 2750 €. It has an SJR impact factor of 0,443 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,443.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Hematology (Q3) Medicine (miscellaneous) (Q3)

Price

2750 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,443

SJR Impact factor

51

H Index

63

Total Docs (Last Year)

256

Total Docs (3 years)

3626

Total Refs

354

Total Cites (3 years)

225

Citable Docs (3 years)

1.35

Cites/Doc (2 years)

57.56

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Swiss Medical Weekly Q3
Neurologia Q3
Canadian Journal of Experimental Psychology Q3
Journal of Physiology and Pharmacology Q3
Revista do Instituto de Medicina Tropical de Sao Paulo Q3

Compare this journals

Aims and Scope

Best articles by citations

Providing leukocyte-reduced platelets using the CS-3000 plus

Autologous peripheral blood stem cell collections in children weighing less than 10 Kg with solid tumors: Experience of a single center

Long-term treatment of myasthenia gravis with immunoadsorption

Pediatric anti-glomerular basement membrane glomerulonephritis

Donor leukocyte infusions and graft-versus-malignancy

Augmented autologous transfusions in major reconstructive spine surgery

Long-term prognosis for Guillain-Barre syndrome: Evaluation of prognostic factors and clinical experience of automated double filtration plasmapheresis

Reply to Ferrero Letter

VEGF levels in patients with peripheral arterial occlusive disease receiving LDL-apheresis

Loss of red cells from the use of blood warmers during apheresis procedures

Bacterial decontamination of blood stem cell apheresis products

Bacterial detection in platelet components and the rationale for pathogen inactivation: A blood center perspective.

SHOW MORE ARTICLES

Photopheresis - A possible treatment of multiple sclerosis? Report of two cases

Treatment of acute occlusion of the retinal artery by LDL-apheresis

Long-term red blood cell exchange can be used to successfully treat sickle cell intrahepatic cholestasis: A case report

Adsorption of anti-annexin V using dextran sulfate bound cellulose beads

Conventional apheresis therapies: A review

Prospective, concurrent comparison of the Cobe Spectra and Haemonetics MCS-3P cell separators for leukapheresis after high-dose filgrastim in patients with hematologic malignancies

Electrolyte monitoring in patients undergoing peripheral blood stem cell collection

Symptomatic hyperviscosity syndrome with polyclonal gammopathy responding to therapeutic plasmapheresis in a patient with myelodysplastic syndrome

Plateletapheresis: Comparison of processing times, platelet yields, and white blood cell content with several commonly used systems

Support of acute liver failure patients with a bioartificial liver

Validation of training and competency of apheresis specialists: Organizational guidelines for therapeutic apheresis facilities

Differentiating thrombotic microangiopathies induced by severe hypertension from anemia and thrombocytopenia seen in thrombotic thrombocytopenia purpura